Vaccine maker Novavax (NASDAQ: NVAX) has fallen harder than the broader market of late, dropping by 36% in the past three months alone. Investors’ views of the biotech have fluctuated along with …
https://www.msn.com/en-us/money/topstocks/will-novavax-hit-250-this-year/ar-AAToAJl

